期刊文献+

四氧嘧啶对人神经瘤SK-N-SH细胞增殖、凋亡的影响及机制探讨 被引量:1

Effect and mechnism of alloxan on multiplication and apoptosis in human neuroblastma cells
下载PDF
导出
摘要 目的观察四氧嘧啶对人神经瘤SK-N-SH细胞增殖和凋亡的影响,并探讨其机制。方法将人神经瘤SK-N-SH细胞分为两组,对照组常规培养12 h,观察组分别加不同浓度的四氧嘧啶培养12 h。用MTT法测细胞吸光度值观察细胞增殖情况,用PI/Hoechst染色法观察细胞凋亡,用蛋白免疫印迹法检测细胞中糖基化和磷酸化的神经丝蛋白。结果对照组细胞吸光度值为0.43±0.01,观察组加入2、4、6、8、10 mM四氧嘧啶作用12 h,细胞吸光度值分别为0.39±0.01、0.35±0.02、0.30±0.01、0.26±0.03、0.21±0.02;观察组与对照组比较,P均<0.05;观察组不同浓度间比较,P均<0.05。对照组细胞凋亡率为5%±1%,观察组加入2、4、6 mM四氧嘧啶作用12 h,细胞凋亡率分别为10%±1%、18%±2%、29%±1%;观察组与对照组比较,P均<0.05;观察组不同浓度间比较,P均<0.05。对照组细胞中磷酸化、糖基化神经丝蛋白OD值为1.00±0.20、1.00±0.20,观察组加入2、4、6 mM四氧嘧啶作用12 h,细胞中磷酸化、糖基化神经丝蛋白OD值分别为1.21±0.42和0.95±0.21、1.32±0.51和0.78±0.32、1.51±0.30和0.75±0.24;观察组与对照组比较,P均<0.05;观察组不同浓度间比较,P均<0.05。结论四氧嘧啶可抑制SK-N-SH细胞增殖,并诱导其凋亡;可能与神经丝蛋白的糖基化降低、磷酸化增加有关。 Objective To observe the effect of alloxan on multiplication and apoptosis in human neuroblastma SK-N- SH cells, and explore the mechanism. Methods Human neuroblastoma SK-N-SH cells were divided into two groups, the control group were cultured routinely for 12 h, the experiment group were cultured with different concentration of alloxan for 12 h. MTT assey was used to observe the multiplication of cells. Pl/Hoechst staining was used to observe cell apoptosis. Western blot was used to detect O-Glycosalytion and phosphorylation of cell neurofilament proteins. Results The OD value of the control group was 0.43 ±0.01, the OD values of the experiment with 2,4,6,8,10 mM of Alloxan for 12 h were 0.39 ± 0.01,0.35 ± 0.02,0.30 ± 0.01, 0.26 ± 0.03, 0.21 ± 0.02 individually ( all P 〈 0.05 ). Apoptosis rate of the control group was 5% ± 1%, apoptosis rate of the experiment group with 2,4,6 mM of alloxan for 12 h were 10% ± 1% ,18% ± 2% ,29% ± 1% individually( all P 〈 0.05). The OD values of phosphorylation and O-Glycosylation of the control group were 1.00 ±0.20 and 1.00 ±0.20 individually, those of the experiment group with 2,4,6,8,10 mM of alloxan for 12 h were 1.21 ±0.42,0.95 ±0.21,1.32 ±0.51,0.78 ±0.32,1.51 ±0.30,0.75 ±0.24 individually( all P 〈0.05). Conclusion Alloxan can inhibit the multiplication of the SK-N-SH cells, and induce apoptosis. It maybe relative to the desease of O-Glycosylation and the increase of phosphorylation of neurofilament proteins.
出处 《山东医药》 CAS 2012年第2期1-3,共3页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30973156) 美国NIHFIRCA国际合作项目(R03TW008123-01A1) 天津市高等学校科技发展基金项目(20070203)
关键词 四氧嘧啶 神经丝蛋白 蛋白糖基化 蛋白磷酸化 细胞增殖 细胞凋亡 alloxan neurofilaments O-Glyeosylation phosphorylation multiplication apoptosis
  • 相关文献

参考文献10

  • 1Cork LC, Sternberger NH, Sternberger LA, et al. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's dis- ease[J]. J Neuropathol Exp Neurol,1986,45( 1 ) :56-64.
  • 2Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N- acetylglucosamine on nucleocytoplasmic proteins [ J ]. Nature, 2007,446(7139) :1017-1022.
  • 3Raina AK, Hochman A, Ickes H, et al. Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out[ J]. Prog Neuro- psychopharmacol Biol Psychiatry, 2003,27 ( 2 ) : 251-254.
  • 4崔冉亮,戎凯,吕朴,胡海燕,褚玉晶,丁楠,邓艳秋.四氧嘧啶脑室内注射对小鼠学习记忆的影响[J].中华神经医学杂志,2011,10(4):346-350. 被引量:3
  • 5Butkinaree C, Park K, Hart GW. O-linked beta-N-acetylglu- cosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress[J]. Biochim Biophys Acta,2010,1800(2) :96-106.
  • 6Deng Y, Li B, Liu F, et al. Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzbeimer disease[J]. FASEB J,2008,22( 1 ) :138-145.
  • 7Deng Y, Li B, Liu Y, et al. Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's dis- ease[J]. Am J Pathol,2009,175(5) :2089-2098.
  • 8Liu Q, Xie F, Siedlak SL, et al. Neurofilament proteins in neuro- degenerative diseases[ J ]. Cell Mol Life Sci, 2004,61 (24) :3057- 3075.
  • 9崔冉亮,胡海燕,吕朴,戎凯,陈宁,邓艳秋.神经丝蛋白质糖基化与磷酸化的相互调节和神经退行性疾病[J].生命的化学,2009,29(6):812-816. 被引量:9
  • 10Jellinger KA. Cell death mechanisms in neurodegeneration [ J ]. J Cell Mol Ned, 2001,5(1) :1-17.

二级参考文献30

  • 1Gotow T et al. Neurofilaments in health and disease. Med Electron Microsc, 2000, 33:173-199.
  • 2Liu Q et al. Neurofilament proteins in neurodegenerative diseases. Cell Mol Life Sci, 2004, 61:3057-3075.
  • 3Lariviere RC et al. Functions of intermediate filaments in neuronal development and disease. J Neurobiol, 2004, 58: 131-148.
  • 4Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci, 2005, 233:183-198.
  • 5Gibb BJ et al. Neuropathological abnormalities in transgenic mice harbouring a phosphorylation mutant neurofilament transgene. J Neurochem, 1998, 70:492-500.
  • 6Jaffe H et al. Characterization of the phosphorylation sites of human high molecular weight neurofilament protein by electrospray Ionization tandem mass spectrometry and database searching. Biochemistry, 1998, 37:3931-3940.
  • 7Sihag RK et al. Role of phosphorylation on the structural dynamics and function of types Ⅲ and Ⅳ intermediate filaments. Exp Cell Res, 2007, 313:2098-2109.
  • 8Gong CX et al. Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices. Neurosci Lett, 2003, 340: 107-110.
  • 9Hart GW et al. Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature, 2007, 446:1017-1022.
  • 10Comer FI et al. O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and Ophosphate. J Biol Chem, 2000, 275:29179-29182.

共引文献10

同被引文献14

  • 1Iqbal K,Liu F,Gong CX. Mechanisms of tau-induced neurodegeneration[J].Acta Neuropathologica,2009,(01):53-69.doi:10.1007/s00401-009-0486-3.
  • 2Lee VM,Balin BJ,Otvos L Jr. A68:a major subunit of paircd helical filaments and derivatized forms of normal Tau[J].Science,1991,(4994):675-678.
  • 3Lefebvre T,Guinez C,Dehennaut V. Does O-GlcNAc play a role in neurodegenerative diseases[J].EXPERT REVIEW OF PROTEOMICS,2005,(02):265-275.
  • 4Gong CX,Liu F,Grundke-Iqbal I. Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation[J].Journal of Alzheimer's Disease,2006,(01):1-12.
  • 5Boglarka L,Susan A,Charlye M. Inhibition of O-GlcNA-case in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner[J].American Journal of Physiology-Heart and Circulatory Physiology,2010,(05):H1715-H1727.
  • 6Gerozissis K. Brain insulin,cnergy and glucose homeostasis,genes,environment and metabolic pathologies[J].European Journal of Pharmacology,2008,(01):38-49.
  • 7Deng Y,Li B,Liu Y. Dysregulation of insulin signaling,glucose transporters,O-GlcNAcylation,and phosphorylation of tau and neurofilaments in the brain:Implication for Alzheimer's disease[J].American Journal of Pathology,2009,(05):2089-2098.
  • 8Fei L,Jianhua S,Hitoshi T. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease[J].Brain,2009,(07):1820-1832.
  • 9Macauley MS,Bubb AK,Martinez-Fleites C. Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance[J].Journal of Biological Chemistry,2008,(50):34687-34695.
  • 10Nobutaka M,Tsuneo Y,Yasuo I. Stable expression in chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)[J].American Journal of Pathology,1999,(06):1649-1656.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部